查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439988

全球椎体压迫性骨折 (VCF) 治疗设备市场：洞察、竞争格局、市场预测：2030 年

Vertebral Compression Fractures (VCF) Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计 2024 年至 2030 年期间，全球椎体压迫骨折 (VCF) 治疗设备市场规模将以 7.5% 的复合年增长率扩大。椎体压迫性骨折（VCF）治疗设备的需求主要由骨质疏鬆症患者人数的增加（导致椎体压迫性骨折（VCF））、人口老化、肥胖等相关危险因子的快速增加所推动。椎骨体压迫性骨折（VCF）治疗装置市场的成长是由产品开发的成长、技术创新等推动的，从而促进了椎体压迫性骨折（VCF）治疗装置市场的整体成长在2024-2030年的预测期内。

根据世界卫生组织（WHO）2022年版报告，肌肉骨骼疾病是造成残疾的主要原因，全球约有17.1亿人患有骨质疏鬆症、骨关节炎、类风湿性关节炎等肌肉骨骼疾病。

根据国际骨质疏鬆基金会（International Osteoporosis Foundation）2021年版数据，2019年英国约有3,775,000名骨质疏鬆患者。

骨质疏鬆症破坏骨微结构，改变骨基质中非胶原蛋白的含量，导致骨密度降低。组织结构的恶化会导致骨头变弱，更容易骨折。

不断增长的老年人口容易患上各种骨科疾病，包括骨质疏鬆症（椎体压迫性骨折（VCF）最常见的原因），这进一步加速了对椎体压迫性骨折（VCF）治疗设备的需求。根据世界卫生组织数据（2023），到2020年，全球将有约10亿人年龄在60岁或以上。到2050年，60岁及以上的人口预计将增加一倍，达到约21亿人。此外，预计 2020 年至 2050 年间，80 岁以上老年人口将增加两倍，达到 4.26 亿人。

该报告调查了全球椎体压迫骨折 (VCF) 治疗设备市场，提供了市场概述、产品类型趋势、手术类型、最终用户、区域趋势以及进入市场的公司概况。

目录

第一章椎体压迫性骨折（VCF）治疗器械市场报告简介

第二章椎体压迫性骨折 (VCF) 治疗设备市场执行摘要

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章椎体压迫性骨折（VCF）治疗器材市场主要因素分析

  • 椎骨压迫性骨折 (VCF) 治疗设备市场驱动因素
  • 椎体压迫骨折（VCF）治疗设备市场的限制与挑战
  • 椎体压迫性骨折 (VCF) 治疗设备市场的机会

第五章椎体压迫性骨折（VCF）治疗器材市场的波特五力分析

第六章椎体压迫性骨折（VCF）治疗设备市场概述

  • 按产品类型
  • 依手术类型
  • 按最终用户
  • 按地区

第七章椎骨压迫性骨折 (VCF) 治疗设备市场公司与产品概况

  • IZI Medical
  • Stryker
  • Globus Medical
  • Amber Implants
  • Medtronic
  • SAFE ORTHOPAEDICS

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第十二章 免责声明与联络我们

Product Code: DIMDCL0669

Vertebral Compression Fractures (VCF) Treatment Devices Market By Product Type (Vertebroplasty Devices And Kyphoplasty Devices), Surgery Type (Open Spine Surgery And Minimally Invasive Spine Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of osteoporosis and growing postmenopausal women population

The global vertebral compression fractures (VCF) treatment devices market is estimated to grow at a CAGR of 7.5% during the forecast period from 2024 to 2030. The demand for vertebral compression fracture (VCF) treatment devices is primarily being boosted by the increasing patient population suffering from osteoporosis which is responsible for causing vertebral compression fracture (VCF), the surge in number of associated risk factors such as old age, obesity, and others, the growing population of postmenopausal women, and innovation in product development among others, thereby contributing to the overall growth of the vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030.

Vertebral Compression Fractures (VCF) Treatment Devices Market Dynamics:

According to the World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

As per the International Osteoporosis Foundation 2021, there were around 3,775,000 individuals with osteoporosis in the United Kingdom in 2019.

The 2023 data based on self-reported data from the Australian Bureau of Statistics (ABS) 2017-18 National Health Survey (NHS) presented by the Australian Institute of Health and Welfare stated that an estimated 924,000 Australians have osteoporosis. As per the same source, there were 9,300 hospitalizations with a principal diagnosis of osteoporosis for people aged 45 and over in 2020-21 in Australia.

Because osteoporosis disturbs bone microarchitecture and changes the content of noncollagenous proteins in the bone matrix, bone mineral density is reduced. This tissue structure degradation results in weak bones that are prone to fractures.

The increasing geriatric population prone to various orthopedic disorders including osteoporosis which is the most common etiology of vertebral compression fractures (VCF), and others is further accelerating the demand for vertebral compression fractures (VCF) treatment devices. According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

The growing postmenopausal women population at risk of osteoporotic bone due to hormonal changes is further going to assist in the market growth. As per WHO 2022, in 2021, women aged 50 and over accounted for 26% of all women and girls globally. This was up from 22% 10 years earlier. The menopausal transition most often begins between ages 45 and 55.

However, the occurrence of post-surgical complications, the stringent regulatory approval for the devices, and reimbursement issues may restrict the growth of the overall vertebral compression fractures (VCF) treatment devices market.

Vertebral Compression Fractures (VCF) Treatment Devices Market Segment Analysis:

Vertebral Compression Fractures (VCF) Treatment Devices Market by Product Type (Vertebroplasty Devices and Kyphoplasty Devices), Surgery Type (Open Spine Surgery and Minimally Invasive Spine Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the vertebral compression fractures (VCF) treatment devices market, the kyphoplasty devices category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with kyphoplasty devices for the effective treatment of vertebral compression fractures (VCF).

Kyphoplasty devices are found to restore vertebral body height and rectify vertebral body deformities. Individuals report a significant and lasting reduction in back discomfort.

Other advantages of kyphoplasty devices include sustained vertebral body height restoration, significant and sustained improvement in quality of life, significant and sustained improvement in mobility, and others.

It reduces the number of days per month when pain interferes with daily activities and improves the overall ability of a person to perform activities walking, hobbies, and work.

A significant reduction in the number of days per month that a patient remains in bed due to back pain is observed after surgery via kyphoplasty devices.

During the surgical procedure, orthopedic balloons are used to restore spinal height and cure angular deformity caused by VCF resulting from osteoporosis, malignancy, or benign lesions. The balloons are deflated and removed after reduction. The cavity formed as a result enables the controlled deposition of bone cement to produce an internal cast and stabilize the fracture.

Therefore, owing to the above-mentioned factors, the kyphoplasty devices category is expected to register significant growth, thereby driving the growth of the overall vertebral compression fractures (VCF) treatment devices market during the forecast period.

North America is expected to dominate the overall Vertebral Compression Fractures (VCF) Treatment Devices Market:

Among all the regions, North America is estimated to account for the largest share of the vertebral compression fractures (VCF) treatment devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of various orthopedic disorders, rise in old age population, surge in cases of injuries and fractures due to sudden accidents, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for vertebral compression fractures (VCF) treatment devices is expected to witness prosperity in the region during the forecast period 2024-2030.

Osteoporosis, a disease characterized by weaker bones that tend to break is highly prevalent across the United States. As per the latest data published by the Office of Disease Prevention and Health Promotion, 1 in 10 people aged 50 years have osteoporosis in the United States. The Bone Health & Osteoporosis Foundation's latest data also mentioned about 10 million people in the US having osteoporosis and another 44 million with low bone density, placing them at increased risk. As per the same source, 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health.

The increasing age makes one susceptible to several health issues including bone diseases, and others, and thus is another driver for the growth of the vertebral compression fractures (VCF) treatment devices market. According to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US.

As per the Administration of Community Living 2021, the population aged 65 and above was 54.1 million, and out of that 30 million were women. Older women are more at risk of suffering from osteoporosis and in turn vertebral compression fractures (VCF).

Thus, the above-mentioned factors are likely to propel the growth of the vertebral compression fractures (VCF) devices market in the region during the forecast period from 2024-2030.

Vertebral Compression Fractures (VCF) Treatment Devices Market Key Players:

Some of the key market players operating in the vertebral compression fractures (VCF) treatment devices market include Medtronic, Stryker, Globus Medical, IZI Medical, Amber Implants, Safe Orthopaedics, and others.

Recent Developmental Activities in the Vertebral Compression Fractures (VCF) Treatment Devices Market:

IZI Medical Products, LLC ("IZI"), a leading manufacturer of interventional radiology devices and products to treat vertebral compression fractures, launched Vertefix HV Cement ("Vertefix HV"), a unique solution that addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

In August 2020, IZI Medical Products, LLC announced the official launch of its Osteo-Site Vertebral Balloon ("Osteo-Site Balloon") for vertebral augmentation.

Key Takeaways from the Vertebral Compression Fractures (VCF) Treatment Devices Market Report Study

Market size analysis for current vertebral compression fractures (VCF) treatment devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global vertebral compression fractures (VCF) treatment devices market.

Various opportunities are available for the other competitors in the vertebral compression fractures (VCF) treatment devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current vertebral compression fractures (VCF) treatment devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vertebral compression fractures (VCF) treatment devices market growth in the coming future?

Target Audience who can be benefited from this Vertebral Compression Fractures (VCF) Treatment Devices Market Report Study

Vertebral Compression fracture (VCF) Treatment Devices product providers

Research organizations and consulting companies

Vertebral Compression Fractures (VCF) Treatment Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vertebral compression fractures (VCF) treatment devices

Various End-users who want to know more about the vertebral compression fractures (VCF) treatment devices market and the latest technological developments in the vertebral compression fractures (VCF) treatment devices market.

Frequently Asked Questions for the Vertebral Compression Fractures (VCF) Treatment Devices Market:

1. What is meant by vertebral compression fracture (VCF) treatment devices?

Vertebral compression fractures (VCF) treatment devices are intended for the treatment of vertebral compression fractures (VCF) of the spine.

2. What is the market for global vertebral compression fractures (VCF) devices?

The global vertebral compression fractures (VCF) treatment devices market is estimated to grow at a CAGR of 7.5% during the forecast period from 2024 to 2030.

3. What are the drivers for the global vertebral compression fractures (VCF) devices market?

The demand for vertebral compression fractures (VCF) treatment devices is primarily being boosted by the increasing patient population suffering from various musculoskeletal disorders like osteoporosis and others, the surge in number of risk factors such as old age, obesity, and others associated with causing spinal problems, rising awareness regarding bone health, growing postmenopausal women population, and others, thereby contributing to the overall growth of the vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global vertebral compression fractures (VCF) treatment devices market?

Some of the key market players operating in the vertebral compression fractures (VCF) treatment devices market include Medtronic, Stryker, Globus Medical, IZI Medical, Amber Implants, Safe Orthopaedics, and others.

5. Which region has the highest share in the vertebral compression fractures (VCF) treatment devices market?

North America is expected to dominate the overall vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of osteoporosis, surge in the old age population, rise in cases of trauma and fractures, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness among others, North American vertebral compression fractures (VCF) devices market is expected to growth in coming years.

Table of Contents

1. Vertebral Compression Fractures (VCF) Treatment Devices Market Report Introduction

2. Vertebral Compression Fractures (VCF) Treatment Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vertebral Compression Fractures (VCF) Treatment Devices Market Key Factors Analysis

  • 4.1. Vertebral Compression Fractures (VCF) Treatment Devices Market Drivers
    • 4.1.1. High prevalence of osteoporosis and other musculoskeletal disorders
    • 4.1.2. Rise in elderly populations, especially postmenopausal women
    • 4.1.3. Increasing accidental injuries and fractures
  • 4.2. Vertebral Compression Fractures (VCF) Treatment Devices Market Restraints and Challenges
    • 4.2.1. Occurrence of post-surgical complications
    • 4.2.2. Stringent regulatory approval for the devices, and reimbursement issues
  • 4.3. Vertebral Compression Fractures (VCF) Treatment Devices Market Opportunities
    • 4.3.1. Increase in awareness about the advancements in spinal surgeries and minimally invasive surgeries
    • 4.3.2. Development of a new generation of injectable bone cement

5. Vertebral Compression Fractures (VCF) Treatment Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Vertebral Compression Fractures (VCF) Treatment Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Vertebroplasty Devices
    • 6.1.2. Kyphoplasty Devices
  • 6.2. By Surgery Type
    • 6.2.1. Open Spine Surgery
    • 6.2.2. Minimally Invasive Spine Surgery
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)

7. Vertebral Compression Fractures (VCF) Treatment Devices Market Company and Product Profiles

  • 7.1. IZI Medical
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Stryker
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Globus Medical
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Amber Implants
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Medtronic
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. SAFE ORTHOPAEDICS
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global (2021-2030)
  • Table 3: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Product Type (2021-2030)
  • Table 4: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Surgery Type (2021-2030)
  • Table 5: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by End-User (2021-2030)
  • Table 6: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Geography (2021-2030)
  • Table 7: Vertebral Compression Fractures (VCF) Treatment Devices Market in North America (2021-2030)
  • Table 8: Vertebral Compression Fractures (VCF) Treatment Devices Market in the US (2021-2030)
  • Table 9: Vertebral Compression Fractures (VCF) Treatment Devices Market in Canada (2021-2030)
  • Table 10: Vertebral Compression Fractures (VCF) Treatment Devices Market in Mexico (2021-2030)
  • Table 11: Vertebral Compression Fractures (VCF) Treatment Devices Market in Europe (2021-2030)
  • Table 12: Vertebral Compression Fractures (VCF) Treatment Devices Market in France (2021-2030)
  • Table 13: Vertebral Compression Fractures (VCF) Treatment Devices Market in Germany (2021-2030)
  • Table 14: Vertebral Compression Fractures (VCF) Treatment Devices Market in the United Kingdom (2021-2030)
  • Table 15: Vertebral Compression Fractures (VCF) Treatment Devices Market in Italy (2021-2030)
  • Table 16: Vertebral Compression Fractures (VCF) Treatment Devices Market in Spain (2021-2030)
  • Table 17: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of Europe (2021-2030)
  • Table 18: Vertebral Compression Fractures (VCF) Treatment Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Vertebral Compression Fractures (VCF) Treatment Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 20: Vertebral Compression Fractures (VCF) Treatment Devices Market in China (2021-2030)
  • Table 21: Vertebral Compression Fractures (VCF) Treatment Devices Market in Japan (2021-2030)
  • Table 22: Vertebral Compression Fractures (VCF) Treatment Devices Market in India (2021-2030)
  • Table 23: Vertebral Compression Fractures (VCF) Treatment Devices Market in Australia (2021-2030)
  • Table 24: Vertebral Compression Fractures (VCF) Treatment Devices Market in South Korea (2021-2030)
  • Table 25: Vertebral Compression Fractures (VCF) Treatment Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of the World (2021-2030)
  • Table 27: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Middle East (2021-2030)
  • Table 28: Vertebral Compression Fractures (VCF) Treatment Devices Market in Africa (2021-2030)
  • Table 29: Vertebral Compression Fractures (VCF) Treatment Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global (2021-2030)
  • Figure 3: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Surgery Type (2021-2030)
  • Figure 5: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by End-User (2021-2030)
  • Figure 6: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Geography (2021-2030)
  • Figure 7: Vertebral Compression Fractures (VCF) Treatment Devices Market in North America (2021-2030)
  • Figure 8: Vertebral Compression Fractures (VCF) Treatment Devices Market in the US (2021-2030)
  • Figure 9: Vertebral Compression Fractures (VCF) Treatment Devices Market in Canada (2021-2030)
  • Figure 10: Vertebral Compression Fractures (VCF) Treatment Devices Market in Mexico (2021-2030)
  • Figure 11: Vertebral Compression Fractures (VCF) Treatment Devices Market in Europe (2021-2030)
  • Figure 12: Vertebral Compression Fractures (VCF) Treatment Devices Market in France (2021-2030)
  • Figure 13: Vertebral Compression Fractures (VCF) Treatment Devices Market in Germany (2021-2030)
  • Figure 14: Vertebral Compression Fractures (VCF) Treatment Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Vertebral Compression Fractures (VCF) Treatment Devices Market in Italy (2021-2030)
  • Figure 16: Vertebral Compression Fractures (VCF) Treatment Devices Market in Spain (2021-2030)
  • Figure 17: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Vertebral Compression Fractures (VCF) Treatment Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Vertebral Compression Fractures (VCF) Treatment Devices Market in China (2021-2030)
  • Figure 20: Vertebral Compression Fractures (VCF) Treatment Devices Market in Japan (2021-2030)
  • Figure 21: Vertebral Compression Fractures (VCF) Treatment Devices Market in India (2021-2030)
  • Figure 22: Vertebral Compression Fractures (VCF) Treatment Devices Market in Australia (2021-2030)
  • Figure 23: Vertebral Compression Fractures (VCF) Treatment Devices Market in South Korea (2021-2030)
  • Figure 24: Vertebral Compression Fractures (VCF) Treatment Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Middle East (2021-2030)
  • Figure 27: Vertebral Compression Fractures (VCF) Treatment Devices Market in Africa (2021-2030)
  • Figure 28: Vertebral Compression Fractures (VCF) Treatment Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis